Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010; Massachusetts Medical Society; Volume: 362; Issue: 15 Linguagem: Inglês
10.1056/nejmoa0904492
ISSN1533-4406
AutoresJean–Fréderic Colombel, William J. Sandborn, Walter Reinisch, Gerassimos J. Mantzaris, Asher Kornbluth, Daniel Rachmilewitz, Simon Lichtiger, Geert R. D’Haens, Robert H. Diamond, Delma L. Broussard, Kezhen L. Tang, C. Janneke van der Woude, Paul Rutgeerts,
Tópico(s)Immunodeficiency and Autoimmune Disorders
ResumoThe comparative efficacy and safety of infliximab and azathioprine therapy alone or in combination for Crohn's disease are unknown.
Referência(s)